Role of the Purkinje System in Long Duration Ventricular Fibrillation
Role of the Purkinje System in Long Duration Ventricular Fibrillation
批准号:
7662604
负责人:
Derek J Dosdall
金额:
$10.48万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-15 至 2011-04-30
关键词:
AblationActinsAction PotentialsAddressAdultAffectAreaArrhythmiaAutomobile DrivingBiologyCalciumCalcium SignalingCaliberCanis familiarisCardiacCardiac OutputCause of DeathCell physiologyCellsCellular biologyCharacteristicsChemicalsDataDiastoleDoseElectric CountershockElectrocardiogramElectrodesEndocardiumEnsureEpicardiumFiberFoundationsFundingGoalsGrantHeartHeart ArrestHeart AtriumHistocompatibility TestingIndividualInstitutionInstructionInterruptionInterventionIschemiaLaboratory ResearchLeadLearningMaintenanceMapsMeasuresMechanicsMembrane PotentialsMentorsMethodsMicroelectrodesModelingMorphologic artifactsMorphologyMotionMovementMyocardialMyocardial tissueMyocardiumMyosin Type IINeedlesOrganPatientsPatternPhasePlayPositioning AttributeQualifyingReportingResearchRoleShockSignal TransductionSinoatrial NodeSiteSodium ChannelSourceStructure of purkinje fibersSubendocardial LayerSurvival RateSystemTechniquesTestingTimeTissuesTrainingUncoupling AgentsVentricularVentricular FibrillationWorkWritingblebbistatinclinically relevantdensityexperienceheart cellimprovedinhibitor/antagonistinsightivabradinememberoptical fiberpreventresearch studyskillssmall moleculesudden cardiac deathsysteminvoltage
中文摘要
描述(由申请人提供):间接证据表明浦肯野系统可能在心室颤动(VF)的最初几分钟后推动快速激活率。该应用建议测量浦肯野系统在维持长时间VF (LDVF)中的作用,并确定浦肯野系统的破坏是否可能终止或显著改变LDVF的激活模式。具体目的1是测量浦肯野系统和工作心肌的跨膜电压和动作电位特征,以确定在LDVF全局缺血和快速激活速率过程中这两种组织类型之间是否有显著变化。我将测试一个假设,即工作心肌膜电位的上升使浦肯野系统的静息电位高于阈值,从而导致浦肯野系统的快速激活。具体目标2是直接绘制和测量LDVF期间浦肯野系统的活性。我们将测试这一假设,即激活出现在浦肯野系统中靠近浦肯野-心肌连接点的部位。具体目标3是化学消融浦肯野系统,以确定浦肯野系统对LDVF激活率和模式的影响。具体目的4是确定是否存在针对浦肯野系统的起搏或药物干预,可能终止室颤或显著降低除颤阈值。在建议工作的指导阶段,我将学习有价值的新的心脏激活制图技术,提高我的演讲和写作技能,并通过课程学习细胞生理学。在指导阶段结束时,我将准备并有资格接受一家领先的研究机构进行心律失常研究的终身职位。在独立阶段,我将继续研究LDVF中的浦肯野系统,并建立一个外部资助的研究实验室,研究心律失常的发生和延续,并开发干预措施,以提高潜在致命性心律失常患者的生存率。相关性(见说明):在美国成年人中,每年大约发生45万例心脏性猝死(SCD)。SCO通常是由室性心动过速引起的,室性心动过速会在几分钟内引起心输出量的急剧减少和重要器官的不可逆损伤。浦肯野系统可能在最初2分钟后的VF维持中发挥重要作用,针对浦肯野系统的治疗可能提高这些患者的生存率。
英文摘要
DESCRIPTION (provided by applicant): Indirect evidence has indicated that the Purkinje system may be driving the rapid activation rate after the first few minutes of ventricular fibrillation (VF). This application proposes to measure the role of the Purkinje system in the maintenance of long duration VF (LDVF) and to determine if disruption of the Purkinje system may terminate or significantly alter LDVF activation patterns. Specific Aim 1 is to measure transmembrane voltage and action potential characteristics of the Purkinje system and working myocardium to determine if there are significant changes between these two tissue types during the global ischemia and rapid activation rate of LDVF. I will test the hypothesis that the rising membrane potential in the working myocardium raises the resting potential in the Purkinje system above threshold, which causes rapid activation within the Purkinje system. Specific Aim 2 is to directly map and measure the activity of the Purkinje system during LDVF. We will test the hypothesis that activation appears focally in the Purkinje system at sites close to Purkinje- myocardial junctions. Specific Aim 3 is to chemically ablate the Purkinje system to determine the influence of the Purkinje system on LDVF activation rates and patterns. Specific Aim 4 is to determine if there are pacing or pharmacological interventions which target the Purkinje system that may terminate VF or significantly lower the defibrillation threshold. During the mentored phase of the proposed work, I will learn valuable new cardiac activation mapping techniques, improve my presentation and writing skills, and learn cellular physiology through coursework. By the end of the mentored phase, I will be prepared and qualified to accept a tenure-track position at a leading research institution conducting cardiac arrhythmia research. During the independent phase, I will continue to investigate the Purkinje system in LDVF and establish an extramurally funded research laboratory to study the initiation and perpetuation of cardiac arrhythmias and to develop interventions to improve survival rates of patients with potentially lethal cardiac arrhythmias. RELEVANCE (See instructions): Approximately 450,000 sudden cardiac deaths (SCD) occur each year among U.S. adults. SCO often results from the onset of VF, which causes a dramatic decrease in cardiac output and irreversible damage to vital organs within a few minutes. The Purkinje system may play an important role in the maintenance of VF after the first 2 minutes and therapy targeting the Purkinje system may improve survival of these patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel lead for selective His bundle sensing and low-threshold pacing
-
批准号:10421275
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2021
-
负责人:Derek J Dosdall
-
依托单位:
A New Approach for Measurement of Electrical Conductivities of Cardiac Tissues
-
批准号:10162414
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2020
-
负责人:Derek J Dosdall
-
依托单位:
Antitachycardia pacing and improved lead for ventricular conduction system stimulation
-
批准号:10478220
-
项目类别:
-
资助金额:$61.18万
-
财政年份:2015
-
负责人:Derek J Dosdall
-
依托单位:
His-Purkinje Pacing for Low Energy Implantable Cardioverter Defibrillators
-
批准号:8944632
-
项目类别:
-
资助金额:$48.72万
-
财政年份:2015
-
负责人:Derek J Dosdall
-
依托单位:
Antitachycardia pacing and improved lead for ventricular conduction system stimulation
-
批准号:10677873
-
项目类别:
-
资助金额:$61.18万
-
财政年份:2015
-
负责人:Derek J Dosdall
-
依托单位:
Antitachycardia pacing and improved lead for ventricular conduction system stimulation
-
批准号:10298724
-
项目类别:
-
资助金额:$61.18万
-
财政年份:2015
-
负责人:Derek J Dosdall
-
依托单位:
Role of the Purkinje System in Long Duration Ventricular Fibrillation
-
批准号:8437167
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2010
-
负责人:Derek J Dosdall
-
依托单位:
Role of the Purkinje System in Long Duration Ventricular Fibrillation
-
批准号:8119222
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:Derek J Dosdall
-
依托单位:
Role of the Purkinje System in Long Duration Ventricular Fibrillation
-
批准号:8135290
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:Derek J Dosdall
-
依托单位:
海外基金